Intellectual Property

Our Leading IP Position

Expanding our intellectual property portfolio is essential in order to successfully implement our strategy and reach our ambition to become a leading biotech in the microbiome industry.

By filing our own IP in the US and Europe, and by licensing in available patents from world class academic, we are building a leadership IP position in the Christensenella space.

LNC Therapeutics filed proprietary patent families protecting christensenella modulation for therapeutic use. In September 2018, we acquired an exclusive licence for the Christensenella patents from Cornell University (Ithaca, NY, USA) covering the applications of Christensenella as a treatment for obesity and metabolic diseases. We’ve also had a number of patents granted by the USPTO.

 

We are actively scouting at the international level for patent licensing opportunities in order to continue expanding our intellectual property portfolio.

Microbiome & us
News
Feb 3, 2020
We are looking for Administrative and Finance Assistant | WHAT WE OFFER An exciting opportunity to dive in and begin...
> more
Jan 13, 2020
We are looking for Clinical Project Manager | WHAT WE OFFER An exciting opportunity to dive in and begin your career...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
Oct 28, 2019
Jillian L. Waters, Ruth E. Ley The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging...
> more
now on twitter
LNC Therapeutics

In a large human study Dr Katerina Johnson found that both gut microbiome composition and diversity were related to… t.co/eufMEnGuo4

LNC Therapeutics © 2020 - all rights reserved terms and conditions